Seminars in urologic oncology Journal

Overview

publication venue for

Nomograms as predictive models.. 20. 2002
Outcome predictions for patients with metastatic prostate cancer.. 20. 2002
Summary of effect of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder (by Harry W. Herr, MD, Carl M. Pinsky, MD, Willet F. Whitmore, Jr, MD, Herbert F. Oettgen, MD, and Myron R. Melamed, MD). 1983.. 15. 1997
Summary of immunohistologic dissection of the human kidney using monoclonal antibodies (by Neil H. Bander, MD, Carlos Cordon-Cardo, MD, PhD, Connie L. Finstad, PhD, Willet F. Whitmore, Jr, MD, E. Darracott Vaughan, Jr, MD, Herbert F. Oettgen, MD, Myron Melamed, MD, and Lloyd J. Old, MD). 1985.. 15. 1997
Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors. 2002
Chemotherapy for good-risk germ-cell tumors. 2002
The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies. 2002
The utility of monoclonal antibodies in the imaging of prostate cancer. 2002
Comparisons of nomograms and urologists' predictions in prostate cancer. 2002
Prostate biopsy techniques and indications: when, where, and how? 2002
Chemotherapy agents in transitional cell carcinoma: the old and the new. 2001
Rising PSAs after primary therapy: active or passive intervention. 1999
Immunological approaches for the treatment of prostate cancer. 1998
High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor. 1997
Bladder preservation and continent urinary diversion in T3b transitional cell carcinoma of the bladder. 1996
Adjuvant chemotherapy for stage II nonseminomatous testicular cancer: what is its role? 1996

Identity

ISO Abbreviation

Semin Urol Oncol

Linking ISSN

1081-0943

International Standard Serial Number (ISSN)

1081-0943